Published in Antimicrob Agents Chemother on October 01, 1991
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother (1997) 2.73
Genome maps of Campylobacter jejuni and Campylobacter coli. J Bacteriol (1992) 2.42
Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother (2005) 1.64
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother (1992) 1.57
Prevalence, antimicrobial susceptibility and virulotyping of Listeria species and Listeria monocytogenes isolated from open-air fish markets. BMC Microbiol (2015) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42
Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A (1971) 5.23
New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and "Campylobacter laridis". J Clin Microbiol (1984) 5.01
Pulsed-field gel electrophoresis of Campylobacter jejuni and Campylobacter coli genomic DNA and its epidemiologic application. J Infect Dis (1991) 4.87
Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci U S A (1980) 4.81
Natural transformation in Campylobacter species. J Bacteriol (1990) 4.07
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol (1990) 4.03
Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics. CRC Crit Rev Biochem (1984) 3.97
Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni. J Bacteriol (1988) 3.53
Cloning and analysis of the promoter region of the erythromycin resistance gene (ermE) of Streptomyces erythraeus. Gene (1985) 3.17
Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J Bacteriol (1985) 2.98
Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother (1987) 2.80
Use of pulsed-field agarose gel electrophoresis to size genomes of Campylobacter species and to construct a SalI map of Campylobacter jejuni UA580. J Bacteriol (1990) 2.65
Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol Gen Genet (1973) 2.59
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus. J Mol Biol (1973) 2.51
Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43
Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31
Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother (1988) 2.26
The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J Infect Dis (1983) 2.17
Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother (1989) 2.05
Rapid purification of highly active ribosomes from Escherichia coli. Anal Biochem (1980) 2.05
Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance. J Antibiot (Tokyo) (1984) 1.85
Contribution of two different mechanisms to erythromycin resistance in Escherichia coli. Antimicrob Agents Chemother (1986) 1.82
Erythromycin-resistant campylobacters. Lancet (1979) 1.82
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother (1986) 1.72
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. Antimicrob Agents Chemother (1989) 1.67
Erythromycin-resistant Campylobacters. Lancet (1978) 1.56
Serotyping by slide agglutination of Campylobacter jejuni and epidemiology. Lancet (1981) 1.51
Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants. J Antimicrob Chemother (1985) 1.42
Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother (1987) 1.34
Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother (1987) 1.27
Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada. Can J Microbiol (1986) 1.25
Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli. J Antimicrob Chemother (1986) 1.13
Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother (1990) 1.05
Sizing and mapping of the genome of Campylobacter coli strain UA417R using pulsed-field gel electrophoresis. Gene (1991) 0.95
Isolation and characterization of Bacillus stearothermophilus 30S and 50S ribosomal protein mutations. J Bacteriol (1990) 0.93
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Pulsed-field gel electrophoresis of Campylobacter jejuni and Campylobacter coli genomic DNA and its epidemiologic application. J Infect Dis (1991) 4.87
Natural transformation in Campylobacter species. J Bacteriol (1990) 4.07
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother (1993) 3.86
Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene (1990) 3.67
Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol (1993) 3.39
Campylobacter fetus diarrhea in a Hutterite colony: epidemiological observations and typing of the causative organism. J Clin Microbiol (1994) 3.31
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
Nomenclature for new tetracycline resistance determinants. Antimicrob Agents Chemother (1999) 2.89
Specification of surface mating systems among conjugative drug resistance plasmids in Escherichia coli K-12. J Bacteriol (1980) 2.82
Use of pulsed-field agarose gel electrophoresis to size genomes of Campylobacter species and to construct a SalI map of Campylobacter jejuni UA580. J Bacteriol (1990) 2.65
Emergency room use and primary care case management: evidence from four Medicaid demonstration programs. Am J Public Health (1989) 2.50
Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother (1989) 2.46
Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1983) 2.40
Mutation as an origin of genetic variability in Helicobacter pylori. Trends Microbiol (1999) 2.37
Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol Microbiol (1996) 2.35
The complete DNA sequence and analysis of R27, a large IncHI plasmid from Salmonella typhi that is temperature sensitive for transfer. Nucleic Acids Res (2000) 2.15
Characterization and expression of a cloned tetracycline resistance determinant from Campylobacter jejuni plasmid pUA466. J Bacteriol (1987) 2.13
Studies of temperature-sensitive transfer and maintenance of H incompatibility group plasmids. J Gen Microbiol (1980) 1.98
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother (2001) 1.88
Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother (1998) 1.76
Incompatibility and bacteriophage inhibition properties of N-1, a plasmid belonging to the H2 incompatibility group. Mol Gen Genet (1977) 1.69
Isolation and characterization of Campylobacter pyloridis from gastric biopsies. Am J Clin Pathol (1987) 1.68
Helicobacter pylori expresses a complex surface carbohydrate, Lewis X. Infect Immun (1995) 1.66
Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol Microbiol (2000) 1.65
Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media. J Clin Microbiol (1985) 1.65
Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene (1988) 1.64
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother (1985) 1.61
Morphological forms and viability of Campylobacter species studied by electron microscopy. J Bacteriol (1985) 1.60
Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant. J Bacteriol (1986) 1.59
Pulsed-field gel electrophoresis for epidemiologic studies of Campylobacter hyointestinalis isolates. J Clin Microbiol (1992) 1.55
Differentiation of the subspecies of Campylobacter fetus by genomic sizing. Int J Syst Bacteriol (1992) 1.55
Selenium metabolism in Escherichia coli. Biometals (1998) 1.50
Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: analysis of the alpha (1,2) fucosyltransferase gene. Mol Microbiol (1999) 1.46
Tellurite-mediated thiol oxidation in Escherichia coli. Microbiology (1999) 1.42
Molecular studies on the mechanism of tetracycline resistance mediated by Tet(O). Antimicrob Agents Chemother (1990) 1.33
Plasmid-mediated resistance to tellurite: expressed and cryptic. Plasmid (1992) 1.29
Association of tellurium resistance and bacteriophage inhibition conferred by R plasmids. J Bacteriol (1979) 1.29
H. pylori DNA Transformation by Natural Competence and Electroporation. Methods Mol Med (1997) 1.28
Comparison of tellurite resistance determinants from the IncP alpha plasmid RP4Ter and the IncHII plasmid pHH1508a. J Bacteriol (1989) 1.28
Gatekeeping the emergency department: impact of a Medicaid primary care case management program. Health Care Manage Rev (1989) 1.27
Cloning and heterologous expression of an alpha1,3-fucosyltransferase gene from the gastric pathogen Helicobacter pylori. J Biol Chem (1997) 1.26
Nucleotide sequence and mutational analysis indicate that two Helicobacter pylori genes encode a P-type ATPase and a cation-binding protein associated with copper transport. Mol Microbiol (1995) 1.26
A DNA sequence upstream of the tet(O) gene is required for full expression of tetracycline resistance. Antimicrob Agents Chemother (1991) 1.25
Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada. Can J Microbiol (1986) 1.25
Biophysics of impact injury to the chest and abdomen. J R Army Med Corps (1989) 1.25
Expression of Escherichia coli TehA gives resistance to antiseptics and disinfectants similar to that conferred by multidrug resistance efflux pumps. Antimicrob Agents Chemother (1997) 1.24
Restriction endonuclease mapping of R27 (TP117), an incompatibility group HI subgroup 1 plasmid from Salmonella typhimurium. Plasmid (1985) 1.23
Characterization of incompatibility group HI1 plasmids from Salmonella typhi by restriction endonuclease digestion and hybridization of DNA probes for Tn3, Tn9, and Tn10. Can J Microbiol (1985) 1.21
Quantification of Hyphomicrobium populations in activated sludge from an industrial wastewater treatment system as determined by 16S rRNA analysis. Appl Environ Microbiol (2000) 1.20
Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology (2001) 1.19
Characterization of chromosomal DNA profiles from Helicobacter pylori strains isolated from sequential gastric biopsy specimens. J Clin Microbiol (1995) 1.17
Localization of the ribosomal protection protein Tet(O) on the ribosome and the mechanism of tetracycline resistance. Mol Cell (2001) 1.17
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1999) 1.16
Contributions of genome sequencing to understanding the biology of Helicobacter pylori. Annu Rev Microbiol (1999) 1.15
Ribosomal protection from tetracycline mediated by Tet(O): Tet(O) interaction with ribosomes is GTP-dependent. Biol Chem (1998) 1.14
Phage inhibition, colicin resistance, and tellurite resistance are encoded by a single cluster of genes on the IncHI2 plasmid R478. J Bacteriol (1995) 1.13
H-pilus assembly kinetics determined by electron microscopy. J Bacteriol (1993) 1.13
Inhibition of bacteriophage lambda, T1, and T7 development by R plasmids of the H incompatibility group. Antimicrob Agents Chemother (1976) 1.13
Identification of DNA homologies among H incompatibility group plasmids by restriction enzyme digestion and Southern transfer hybridization. Antimicrob Agents Chemother (1983) 1.12
Corrected identity of isolates of Helicobacter pylori reference strain NCTC11637. Helicobacter (1997) 1.12
Host range and transfer efficiency of incompatibility group HI plasmids. Can J Microbiol (1993) 1.12
Transmissible tetracycline resistance in Campylobacter jejuni. Lancet (1980) 1.12
Helicobacter pylori genes hpcopA and hpcopP constitute a cop operon involved in copper export. FEMS Microbiol Lett (1996) 1.11
Incidence of plasmid DNA in Salmonella strains isolated from clinical sources in Ontario, Canada, during 1979 and 1980. Can J Microbiol (1982) 1.11
Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys (1997) 1.09
Comparison of basal media for culturing Campylobacter jejuni and Campylobacter coli. J Clin Microbiol (1985) 1.09
Novel Helicobacter pylori alpha1,2-fucosyltransferase, a key enzyme in the synthesis of Lewis antigens. Microbiology (1999) 1.08
Molecular characterization of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori. J Bacteriol (1994) 1.08
Escherichia coli TehB requires S-adenosylmethionine as a cofactor to mediate tellurite resistance. J Bacteriol (2000) 1.08
Aneurysm jig for anastomosis technique. Ann R Coll Surg Engl (1987) 1.06
Characterization of a plasmid mutation affecting maintenance, transfer and elimination by novobiocin. Mol Gen Genet (1979) 1.06
Flow through the mitral valve during diastolic filling of the left ventricle. J Physiol (1969) 1.06
The biosynthesis of Lewis X in Helicobacter pylori. Glycobiology (1995) 1.06
Incompatibility and surface exclusion properties of H1 and H2 plasmids. J Bacteriol (1977) 1.05
Classification of Campylobacter strains using DNA probes. Mol Cell Probes (1987) 1.05
Characterization of freshly isolated Campylobacter coli strains and suitability of selective media for their growth. J Clin Microbiol (1988) 1.05
The tellurite-resistance determinants tehAtehB and klaAklaBtelB have different biochemical requirements. Microbiology (1995) 1.05
Variability of IncHI1 plasmids from Salmonella typhi with special reference to Peruvian plasmids encoding resistance to trimethoprim and other antibiotics. Antimicrob Agents Chemother (1985) 1.04
Mapping of transfer regions within incompatibility group HI plasmid R27. J Bacteriol (1985) 1.04
Nucleotide sequence and overexpression of the tellurite-resistance determinant from the IncHII plasmid pHH1508a. Gene (1991) 1.03
Transcriptional analysis, translational analysis, and sequence of the kilA-tellurite resistance region of plasmid RK2Ter. J Bacteriol (1991) 1.03
Transfer-defective and tetracycline-sensitive mutants of the incompatibility group HI plasmid R27 generated by insertion of transposon 7. Plasmid (1983) 1.03
Synthesis of mono- and di-fucosylated type I Lewis blood group antigens by Helicobacter pylori. Eur J Biochem (2000) 1.03
Glutathione is a target in tellurite toxicity and is protected by tellurite resistance determinants in Escherichia coli. Can J Microbiol (2001) 1.02
Acrolein-induced cell death in human alveolar macrophages. Toxicol Appl Pharmacol (1997) 1.01
Characterization of a region of the IncHI2 plasmid R478 which protects Escherichia coli from toxic effects specified by components of the tellurite, phage, and colicin resistance cluster. J Bacteriol (1997) 1.00
Cellular location and temperature-dependent assembly of IncHI1 plasmid R27-encoded TrhC-associated conjugative transfer protein complexes. Mol Microbiol (2001) 1.00
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother (2003) 0.99
Effect of mutational alteration of Asn-128 in the putative GTP-binding domain of tetracycline resistance determinant Tet(O) from Campylobacter jejuni. Antimicrob Agents Chemother (1993) 0.99
Analysis of the complete nucleotide sequence of the tetracycline-resistance transposon Tn10. Plasmid (2000) 0.97
Plasmid content and pathogenicity of Campylobacter jejuni and Campylobacter coli strains in the pregnant guinea pig model. Am J Vet Res (1984) 0.97
Current concepts in the treatment of common compartment syndromes in athletes. Sports Med (1993) 0.97
Arthroscopic treatment of adhesive capsulitis. J Shoulder Elbow Surg (1996) 0.96